Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 4887 Records) |
| Query Trace: Neoplasms and EGFR[original query] |
|---|
| Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications. Molecular oncology 2023 11 . Sara Hijazo-Pechero, Ania Alay, David Cordero, Raúl Marín, Noelia Vilariño, Ramón Palmero, Jesús Brenes, Aina Montalban-Casafont, Ernest Nadal, Xavier So |
| Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC. The New England journal of medicine 2023 11 . David Planchard, Pasi A Jänne, Ying Cheng, James C-H Yang, Noriko Yanagitani, Sang-We Kim, Shunichi Sugawara, Yan Yu, Yun Fan, Sarayut L Geater, Konstantin Laktionov, Chee K Lee, Natalia Valdiviezo, Samreen Ahmed, Jean-Marc Maurel, Igor Andrasina, Jonathan Goldman, Dana Ghiorghiu, Yuri Rukazenkov, Alex Todd, Kunihiko Kobayashi, |
| Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies. British journal of cancer 2023 11 . A Leonetti, M Verzè, R Minari, F Perrone, L Gnetti, P Bordi, M Pluchino, R Nizzoli, C Azzoni, L Bottarelli, C A M Lagrasta, G Mazzaschi, S Buti, D Gasparro, A Cosenza, L Ferri, M Majori, M De Filippo, L Ampollini, S La Monica, R Alfieri, E M Silini, M Tis |
| Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. Frontiers in immunology 2023 11 14 1282734. Qisheng Luo, Junhong Zhuang, Dandan Zheng, Changfeng Miao, Hongcheng Luo, Jun Peng, Chuanhua Zheng, Chengjian Qin, Chuanliu Lan, Meiqin Chen, Ying Xia, Deyou Huang, Zigui Ch |
| SMARCA4?deficient non?small cell lung cancer with an EGFR mutation: A case report. Oncology letters 2023 11 26 (6): 513. Lijun Sun, Qiong Fu, Lijiang Chen, Meijuan Di, Jianhua C |
| Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis. Clinical lung cancer 2023 11 . Fumihiro Kashizaki, Hao Chen, Atsushi Miyasaka, Nanami Tsuchiya, Chihiro Yamada, Shunsuke Okazaki, Mai Kaneko, Taiki Kano, Yohei Kameda, Akitomo Kikuchi, Kentaro Yumoto, Hiroyuki Osawa, Harumi Koizumi, Kenichi Takahashi, Takeshi Kane |
| Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals. European journal of medical research 2023 11 28 (1): 478. Jing Ren, Yuan Wang, Chunrong Liu, Lan Yang, Xinlu Men, Zhixin Q |
| DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
| Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers. Targeted oncology 2023 11 . Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B Cort |
| Effectiveness comparison of third-generation EGFR-TKI as initial and sequential therapy in adjuvant treatment for EGFR mutation-sensitive stage IIIA non-small cell lung cancer after surgery. Heliyon 2023 11 9 (11): e20955. Wenyan Ma, Ziyi Sheng, Yongliang Niu, Bo Yan, Yong Chen, Haitang Yang, Rong |
| Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer. Cancer research and treatment 2023 11 . Patinya Akkhasutthikun, Pornchai Kaewsapsak, Pattaraporn Nimsamer, Pavit Klomkliew, Suthida Visedthorn, Pragwalai Chanchaem, Chinachote Teerapakpinyo, Sunchai Payungporn, Sutima Luangdil |
| Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC. Scientific reports 2023 11 13 (1): 20323. Jia-Shiuan Ju, Allen Chung-Cheng Huang, Pi-Hung Tung, Chi-Hsien Huang, Tzu-Hsuan Chiu, Chin-Chou Wang, How-Wen Ko, Fu-Tsai Chung, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Ya |
| Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
| Allelic context of EGFR C797X mutant lung cancer defines four subtypes with heterogeneous genomic landscape and distinct clinical outcomes. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 11 . Chang Lu, Xue-Wu Wei, Zhen Wang, Zhen Zhou, Yu-Tao Liu, Di Zheng, Yong He, Zhan-Hong Xie, Yong Li, Yan Zhang, Yi-Chen Zhang, Zi-Jian Huang, Shi-Qi Mei, Jia-Qi Liu, Xu-Hui Guan, Yu Deng, Zhi-Hong Chen, Hai-Yan Tu, Chong-Rui Xu, Hua-Jun Chen, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Tony S K Mok, Yi-Long Wu, Qing Zh |
| Pan-tumor analytical validation and osimertinib clinical validation in EGFR mutant non-small cell lung cancer, supporting the first next generation sequencing liquid biopsy in vitro diagnostic. The Journal of molecular diagnostics : JMD 2023 11 . Jhanelle E Gray, Ji-Youn Han, Aino Telaranta-Keerie, Xiangning Huang, Alexander Kohlmann, Rachel Hodge, Yuri Rukazenkov, Juliann Chmielecki, Carin R Espenschied, Martina Lefterova, Yi-Long Wu, Suresh S Ramalingam, J Carl Barrett, Justin I Odegaa |
| Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
| Air bronchogram on chest CT in radiological pure-solid appearance lung cancer: Correlation analysis with genetic pathological features and survival outcomes. European journal of radiology 2023 11 169 111194. Zijian Wang, Wei Zhu, Menghang Yang, He Du, Fei Zhou, Nan Song, Ziwei Wan, Jingqi Zhu, Wei |
| Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images. Physics in medicine and biology 2023 11 . Jing Gong, Fangqiu Fu, Xiaowen Ma, Ting Wang, Xiangyi Ma, Chao You, Yang Zhang, Weijun Peng, Haiquan Chen, Yajia |
| Association between cigarette smoking history, metabolic phenotypes, and EGFR mutation status in patients with non-small cell lung cancer. Journal of thoracic disease 2023 11 15 (10): 5689-5699. Xiaohui Zhang, Xiuyu Guo, Qiaoling Gao, Jingfeng Zhang, Jianjun Zheng, Guofang Zhao, Katsuhiro Okuda, Alfredo Tartarone, Maoqing Jia |
| Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
| Effect of pre-treatment of EGFR-TKIs on immune checkpoint inhibitor-associated interstitial lung disease in lung cancer patients: Analysis using a Japanese claims database. International journal of clinical pharmacology and therapeutics 2023 11 . Naoto Okada, Hirofumi Hamano, Kenta Yagi, Takahiro Niimura, Fuka Aizawa, Mitsuhiro Goda, Yoshito Zamami, Takashi Kitahara, Keisuke Ishiza |
| Comparison and Validation of Rapid Molecular Testing Methods for Theranostic Epidermal Growth Factor Receptor Alterations in Lung Cancer: Idylla versus Digital Droplet PCR. International journal of molecular sciences 2023 11 24 (21): . Camille Léonce, Clémence Guerriau, Lara Chalabreysse, Michaël Duruisseaux, Sébastien Couraud, Marie Brevet, Pierre-Paul Bringuier, Delphine Aude Ponc |
| Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer. Scientific reports 2023 11 13 (1): 19729. Takeshi Masuda, Satoru Miura, Yuki Sato, Motoko Tachihara, Akihiro Bessho, Atsushi Nakamura, Taichi Miyawaki, Kohei Yoshimine, Masahide Mori, Hideaki Shiraishi, Kosuke Hamai, Koji Haratani, Sumiko Maeda, Eriko Tabata, Chiyoe Kitagawa, Junko Tanizaki, Takumi Imai, Shohei Nogami, Nobuyuki Yamamoto, Kazuhiko Nakagawa, Noboru Hatto |
| A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer. Cancer 2023 10 . Bianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, Lizza E L Hendriks, Sayed M S Hashemi, Antonios Daletzakis, Daan van den Broek, Linda J W Bosch, Kim Monkhorst, Egbert F Smit, Adrianus J de Lang |
| Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. Journal of neuro-oncology 2023 10 . Kaixuan Bai, Xin Chen, Xuejiao Qi, Yu Zhang, Yueli Zou, Jian Li, Lili Yu, Yuanyuan Li, Jiajia Jiang, Yi Yang, Yajing Liu, Shuanghao Feng, Hui |
| Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence. Diagnostics (Basel, Switzerland) 2023 10 13 (20): . Seong Hyeon Yu, Sung Sun Kim, Hyungki Lee, Shinseung Kim, Taek Won Ka |
| Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers. Cancer cell 2023 10 . Evelyn Jiagge, Dexter X Jin, Justin Y Newberg, Tomin Perea-Chamblee, Kelly R Pekala, Christopher Fong, Michele Waters, David Ma, Yvonne Dei-Adomakoh, Gilles Erb, Kanika S Arora, Sophia L Maund, Njoki Njiraini, Atara Ntekim, Susie Kim, Xuechun Bai, Marlene Thomas, Ronwyn van Eeden, Priti Hegde, Justin Jee, Debyani Chakravarty, Nikolaus Schultz, Michael F Berger, Garrett M Frampton, Ethan S Sokol, Jian Carrot-Zha |
| Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: